Adriamycin and bleomycin, alone and in c
โ
Drs. J. J. Barlow; M. S. Piver; J. T. Chuang; Drs. E. P. Cortes; T. Ohnuma; J. F
๐
Article
๐
1973
๐
John Wiley and Sons
๐
English
โ 663 KB
Treatment with adriamycin (ADM) and bleomycin (BLEO) alone and in combination has been evaluated in 56 patients with a variety of advanced stage gynecologic cancers. ADM has a high degree of antitumor activity against uterine sarcomas (leiomyosarcoma and stromal sarcoma) and some of the unusual ovar